Abstract
Background Low birth weight (LBW) is a critical factor linked to neonatal morbidity and mortality. Early prediction is essential for timely interventions. This study aimed to develop and evaluate predictive models for LBW using machine learning algorithms, including Random Forest, XGBoost, Catboost, and LightGBM.
Methods Machine learning algorithms (Random Forest, XGBoost, Catboost, and LightGBM) were trained and evaluated using cross-validation and the SMOTE technique to correct class imbalance. Model performance was measured using the AUROC metric, and variable importance was analyzed with Shapley values to ensure model interpretability.
Results The XGBoost model achieved the best performance with an AUROC of 0.94. Catboost and Random Forest also showed excellent results, confirming the effectiveness of these models in predicting LBW.
Conclusion Machine learning, combined with SMOTE, proved to be an effective approach for predicting LBW. XGBoost stood out as the most accurate model, but Catboost and Random Forest also provided solid results. These models can be applied to identify high-risk pregnancies, improving perinatal outcomes through early interventions.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Research Ethics Committee of the School of Public Health, University of São Paulo (USP), prior to data collection. The approval was granted under the CAEE number 59787216.2.0000.5421, with opinion number 1.885.874. All participants provided informed consent in accordance with the ethical standards outlined in the Helsinki Declaration.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Data Availability
Data Availability Statement Response The data from the Araraquara cohort cannot be shared publicly due to ethical and confidentiality concerns. The cohort includes sensitive personal health information that is protected by the Brazilian General Data Protection Law (Lei Geral de Proteção de Dados – LGPD). Additionally, the participants provided informed consent for their data to be used only in the context of specific research projects and not for public distribution. However, data access can be requested through the Research Ethics Committee of the School of Public Health, University of São Paulo (USP), upon approval. Researchers interested in accessing the data should contact the committee via, provided they meet the necessary criteria for handling confidential and sensitive data.
